Susan Pocchiari has over fifteen years of experience providing counsel to clients in the biotechnology and biopharmaceutical industries on intellectual property matters. She has experience as both in-house intellectual property counsel as well as in private practice. In addition, Susan has a doctorate in the field of cancer immunology.

As in-house IP counsel at Boehringer Ingelheim, one of the top twenty pharmaceutical companies in the world, Dr. Pocchiari’s experience spanned a wide range of technical areas within the life sciences, including, for example, biotechnology, biochemistry, veterinary health, and pharmaceuticals.

Previously, Dr. Pocchiari was an associate at Pennie & Edmonds LLP, a large, New York City-based law firm that specialized in intellectual property. In private practice, she assisted a variety of clients ranging from startups to global corporations with the development and protection of intellectual property assets.

Dr. Pocchiari’s practice is focused on a wide array of specific technologies that have included therapeutic molecules, e.g., recombinant nucleic acids, proteins, peptides and antibodies, gene therapies, vaccines, and synthetic tissue scaffolds; transgenic animals; genomic and proteomic tools and assays; high-throughput screening assays; dietary supplements; medical diagnostics; and biopharmaceuticals.

Dr. Pocchiari received her J.D. from SUNY Buffalo Law School (1996) and her Ph.D. in microbiology and immunology from Roswell Park Cancer Institute, a division of SUNY Buffalo (1996).

She is admitted in practice in New York and the United States Patent and Trademark Office.